Use of XXXX in @entity4422 and in the treatment of post-traumatic @entity4034 .

@entity1 @entity4422 @entity4034 @entity294 @entity794 @entity281 @entity79 @entity10 @entity56 @entity9244 @entity800
In two open prospective studies, the efficacy and tolerance of @entity800 in the prevention of @entity281 in @entity1 with @entity4422 (n = 58) and in the treatment of chronic post-traumatic @entity4034 (n = 115) were examined. In the study with @entity4422 , @entity9244 occurred in only four cases (6.5%). During an observation period of at least 12 months, post-traumatic @entity4034 was seen in two @entity1 with III degree @entity4422 (9%), while in the groups with I degree and II degree @entity4422 no @entity79 could be found. Therefore, the rate of post-traumatic @entity4034 related to all @entity1 was 3.3%. In the second study with 115 @entity1 suffering from chronic post-traumatic @entity4034 141 different Gram-positive and Gram-negative pathogens were isolated. 73% were Gram-positive cocci with @entity794 in more than 50% of the cases. An elimination rate of more than 90% was found in the Gram-positive and Gram-negative bacteria, leading to a clinical cure in 85% and a recurrence of @entity281 in 5% of the cases. The tolerability of @entity800 was excellent. No @entity56 were observed. @entity294 and @entity10 occurred in less than 2% of @entity1 . With adequate surgical treatment, @entity800 proved to be a useful antimicrobial agent in the prevention and therapy of @entity79 .
